Abstract
Gray-zone lymphoma (GZL) reflects an aggressive B-cell neoplasm with features intermediate between diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma (cHL). The International Prognostic Index (IPI) and its derivatives (R-IPI, NCCN-IPI, and the Hasenclever IPS) have been established for DLBCL or cHL while the most suitable scoring system for GZL remains undetermined. In an exploratory multi-centric cohort of GZL (n = 61), we performed a comparative analysis of prognostic indices with regard to model fit and mutual concordance. The calculation of the corrected Akaike’s information criterion (cAIC) and Harrel’s concordance index (c-index) for each scoring system identified the NCCN-IPI to harbor the most convincing prognostic capabilities regarding both overall survival (OS) and progression-free survival (PFS) compared to its enhanced derivatives. The current results affirm the clinical utility of the NCCN-IPI and suggest its preferential use in clinical practice in GZL-patients.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Leukemia and Lymphoma |
| Jahrgang | 63 |
| Ausgabenummer | 4 |
| Seiten (von - bis) | 894-902 |
| Seitenumfang | 9 |
| ISSN | 1042-8194 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2022 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Profilbereich: Lübeck Integrated Oncology Network (LION)
- Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)
- Querschnittsbereich: Medizinische Genetik
DFG-Fachsystematik
- 2.22-14 Hämatologie, Onkologie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Comparative analysis of international prognostic indices in gray-zone lymphoma“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver